Form 4: ResMed Inc. Executive Michael J. Rider Reports Stock Sale
SEC Form 4 Filing
Michael J. Rider, Global General Counsel of ResMed Inc., reports the sale of 81 shares of common stock at $180 per share.
Summary
- On March 4, 2024, Michael J. Rider, the Global General Counsel of ResMed Inc., sold 81 shares of ResMed Common Stock.
- The sale was executed at a price of $180 per share.
- Following the transaction, Rider directly owns 6,607 shares of ResMed Common Stock.
- The transaction was conducted under a Rule 10b5-1 plan adopted on November 29, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine stock sale by an executive under a pre-arranged trading plan.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The sale by the Global General Counsel is not necessarily indicative of the company's performance or future prospects.
Key Dates
| Date | Description |
|---|---|
| 2023-11-29 | Date of adoption of Rule 10b5-1 plan |
| 2024-03-04 | Date of stock sale transaction |
| 2024-03-06 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.